WHO ICTRP trial
A comparison of two low-intensity transplant regimens for the treatment of…
EUCTR2017-004800-23-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-004800-23-GB |
|---|---|
| Public title | A comparison of two low-intensity transplant regimens for the treatment of adults with acute lymphoblastic leukaemia (ALL) over the age of 40 years (ALL-RIC) |
| Scientific title | A comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remission. - ALL-RIC |
| Primary sponsor | University of Birmingham |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Acute Lymphoblastic Leukaemia (ALL) MedDRA version: 20.1 Level: LLT Classification code 10000844 Term: Acute lymphoblastic leukaemia System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Product Name: Cyclophosphamide Product Code: Cyclophosphamide Pharmaceutical Form: Powder for solution for infusion INN or Proposed INN: cyclophosphamide CAS Number: 50-18-0 Current Sponsor code: Cyclophosphamide Concentration unit: mg/kg… |
| Registration date | Feb 8, 2018 |
| Target size | 242 |
| Secondary IDs | RG-17-241 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: